Liver regeneration: A spotlight on the novel role of platelets and serotonin

Swiss Medical Weekly

Volumn 138, Issue 25-26, 2008, Pages 361-370

  Clavien, Pierre Alain ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Department of Visceral Surgery and Transplantation ^*  (Switzerland)

Author keywords

Liver regeneration; Platelets; Serotonin

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; KERATINOCYTE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; SEROTONIN; SEROTONIN 2 RECEPTOR; SEROTONIN RECEPTOR; SOMATOMEDIN; THROMBOPOIETIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

COLD ISCHEMIA; CYTOKINE RELEASE; HUMAN; LIVER REGENERATION; LIVER SURGERY; LIVER TRANSPLANTATION; MOLECULAR DYNAMICS; PARTIAL HEPATECTOMY; REPERFUSION INJURY; REVIEW; SEROTONIN METABOLISM; SYNTHESIS; THROMBOCYTE;

EID: 47049118666     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (117)

1. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007;356:1545-59.
2. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl. 2003;9:651-63.
3. Tanaka K, Kiuchi T, Kaihara S. Living related liver donor transplantation: techniques and caution. Surg Clin North Am. 2004; 84:481-93.
4. Dahm F, Georgiev P, Clavien PA. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant. 2005;5:2605-10.
5. Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology. 2004;39:1477-87.
6. Michalopoulos GK, DeFrances MC. Liver regeneration. Science. 1997;276:60-6.
7. Hata S, Namae M, Nishina H. Liver development and regeneration: from laboratory study to clinical therapy. Dev Growth Differ. 2007;49:163-70.
8. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology. 2006;43:45-53.
9. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol. 2004;5:836-47.
10. Barbason H, Herens C, Robaye B, Milis G, Sulon J, Bouzahzah B, VanCantfort J. Importance of cell kinetics rhythmicity for the control of cell proliferation and carcinogenesis in rat liver (review). In Vivo. 1995;9:539-48.
11. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science. 2003;302:255-9.
12. Schibler U. Circadian rhythms. Liver regeneration clocks on. Science. 2003;302:234-5.
13. Carr BI, Hayashi I, Branum EL, Moses HL. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor. Cancer Res. 1986;46:2330-4.
14. Martinez-Hernandez A, Amenta PS. The extracellular matrix in hepatic regeneration. Faseb J. 1995;9:1401-10.
15. Kam I, Lynch S, Svanas G, Todo S, Polimeno L, Francavilla A, Penkrot RJ, et al. Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants. Hepatology. 1987;7:362-6.
16. Van Thiel DH, Gavaler JS, Kam I, Francavilla A, Polimeno L, Schade RR, Smith J, et al. Rapid growth of an intact human liver transplanted into a recipient larger than the donor. Gastroenterology. 1987;93:1414-9.
17. Francavilla A, Zeng Q, Polimeno L, Carr BI, Sun D, Porter KA, Van Thiel DH, et al. Small-for-size liver transplanted into larger recipient: a model of hepatic regeneration. Hepatology. 1994;19:210-6.
18. Tian Y, Jochum W, Georgiev P, Moritz W, Graf R, Clavien PA. Kupffer cell-dependent TNF-alpha signaling mediates injury in the arterialized small-for-size liver transplantation in the mouse. Proc Natl Acad Sci USA. 2006;103:4598-603.
19. Campbell JS, Prichard L, Schaper F, Schmitz J, Stephenson-Famy A, Rosenfeld ME, Argast GM, et al. Expression of suppressors of cytokine signaling during liver regeneration. J Clin Invest. 2001;107:1285-92.
20. Cornell RP. Gut-derived endotoxin elicits hepatotrophic factor secretion for liver regeneration. Am J Physiol. 1985;249:551-62.
21. Cornell RP, Liljequist BL, Bartizal KF. Depressed liver regeneration after partial hepatectomy of germ-free, athymic and lipopolysaccharide-resistant mice. Hepatology. 1990;11:916-22.
22. Akerman P, Cote P, Yang SQ, McClain C, Nelson S, Bagby GJ, Diehl AM. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol. 1992;263:579-85.
23. Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA. 1997;94:1441-6.
24. Yamada Y, Webber EM, Kirillova I, Peschon JJ, Fausto N. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. Hepatology. 1998;28:959-70.
25. Michalopoulos GK, DeFrances M. Liver regeneration. Adv Biochem Eng Biotechnol. 2005;93:101-34.
26. Webber EM, Bruix J, Pierce RH, Fausto N. Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology. 1998;28:1226-34.
27. Northemann W, Hattori M, Baffet G, Braciak TA, Fletcher RG, Abraham LJ, Gauldie J, et al. Production of interleukin 6 by hepatoma cells. Mol Biol Med. 1990;7:273-85.
28. Michalopoulos GK. Liver regeneration. J Cell Physiol. 2007;213:286-300.
29. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 1996;274:1379-83.
30. Sakamoto T, Liu Z, Murase N, Ezure T, Yokomuro S, Poli V, Demetris AJ. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology. 1999;29:403-11.
31. Liu Z, Sakamoto T, Ezure T, Yokomuro S, Murase N, Michalopoulos G, Demetris AJ. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium. Hepatology. 1998;28:1260-8.
32. Selzner M, Camargo CA, Clavien PA. Ischemia impairs liver regeneration after major tissue loss in rodents: protective effects of interleukin-6. Hepatology. 1999;30:469-75.
33. Selzner M, Clavien PA. Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. Hepatology. 2000;31:35-42.
34. Nozaki I, Lunz JG, 3rd, Specht S, Stolz DB, Taguchi K, Subbotin VM, Murase N, et al. Small proline-rich proteins 2 are non-coordinately upregulated by IL-6/STAT3 signaling after bile duct ligation. Lab Invest. 2005;85:109-23.
35. Demetris AJ, Lunz JG, 3rd, Specht S, Nozaki I. Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease. World J Gastroenterol. 2006;12:3512-22.
36. Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit Rev Oncog. 1992;3:27-54.
37. Stella MC, Comoglio PM. HGF: a multifunctional growth factor controlling cell scattering. Int J Biochem Cell Biol. 1999;31:1357-62.
38. Lindroos PM, Zarnegar R, Michalopoulos GK. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology. 1991;13:743-50.
39. Appasamy R, Tanabe M, Murase N, Zarnegar R, Venkatarama-nan R, Van Thiel DH, Michalopoulos GK. Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats. Lab Invest. 1993;68:270-6.
40. Liu ML, Mars WM, Zarnegar R, Michalopoulos GK. Collagenase pretreatment and the mitogenic effects of hepatocyte growth factor and transforming growth factor-alpha in adult rat liver. Hepatology. 1994;19:1521-7.
41. Patijn GA, Lieber A, Schowalter DB, Schwall R, Kay MA. Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice. Hepatology. 1998;28:707-16.
42. Pediaditakis P, Lopez-Talavera JC, Petersen B, Monga SP, Michalopoulos GK. The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology. 2001;34:688-93.
43. Block GD, Locker J, Bowen WC, Petersen BE, Katyal S, Strom SC, Riley T, et al. Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium. J Cell Biol. 1996;132:1133-49.
44. Naldini L, Vigna E, Narsimhan RP, Gaudino G, Zarnegar R, Michalopoulos GK, Comoglio PM. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene. 1991;6:501-4.
45. Stolz DB, Mars WM, Petersen BE, Kim TH, Michalopoulos GK. Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat. Cancer Res. 1999;59:3954-60.
46. Borowiak M, Garratt AN, Wustefeld T, Strehle M, Trautwein C, Birchmeier C. Met provides essential signals for liver regeneration. Proc Natl Acad Sci USA. 2004;101:10608-13.
47. Jones DE, Jr., Tran-Patterson R, Cui DM, Davin D, Estell KP, Miller DM. Epidermal growth factor secreted from the salivary gland is necessary for liver regeneration. AmJPhysiol. 1995;268:872-8.
48. Burgess AW, Lloyd CJ, Smith S, Stanley E, Walker F, Fabri L, Simpson RJ, et al. Murine epidermal growth factor: structure and function. Biochemistry. 1988;27:4977-85.
49. Skov Olsen P, Boesby S, Kirkegaard P, Therkelsen K, Almdal T, Poulsen SS, Nexo E. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology. 1988;8:992-6.
50. St Hilaire RJ, Hradek GT, Jones AL. Hepatic sequestration and biliary secretion of epidermal growth factor: evidence for a high-capacity uptake system. Proc Natl Acad Sci USA. 1983;80:3797-3801.
51. Ikeda H, Nagoshi S, Ohno A, Yanase M, Maekawa H, Fujiwara K. Activated rat stellate cells express c-met and respond to hepatocyte growth factor to enhance transforming growth factor betal expression and DNA synthesis. Biochem Biophys Res Commun. 1998;250:769-75.
52. Houck KA, Michalopoulos GK. Altered responses of regenerating hepatocytes to norepinephrine and transforming growth factor type beta. J Cell Physiol. 1989;141:503-9.
53. Gohda E, Matsunaga T, Kataoka H, Yamamoto I. TGF-beta is a potent inhibitor of hepatocyte growth factor secretion by human fibroblasts. Cell Biol Int Rep. 1992;16:917-26.
54. Mars WM, Kim TH, Stolz DB, Liu ML, Michalopoulos GK. Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor. Cancer Res. 1996;56:2837-43.
55. Russell WE, Coffey RJ, Jr., Ouellette AJ, Moses HL. Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA. 1988;85:5126-30.
56. Chari RS, Price DT, Sue SR, Meyers WC, Jirtle RL. Down-regulation of transforming growth factor beta receptor type I, II, and III during liver regeneration. Am J Surg 1995;169:126-31; discussion. 131-2.
57. Houck KA, Cruise JL, Michalopoulos G. Norepinephrine modulates the growth-inhibitory effect of transforming growth factor-beta in primary rat hepatocyte cultures. J Cell Physiol. 1988;135:551-5.
58. Pepper MS, VassalliJD, Orci L, Montesano R. Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis. Exp Cell Res. 1993;204:356-63.
59. Holifield JS, Arlen AM, Runyan RB, Tomanek RJ. TGF-betal, -beta2 and -beta3 cooperate to facilitate tubulogenesis in the explanted quail heart. J Vasc Res. 2004;41:491-8.
60. Murphy MO, Ghosh J, Fulford P, Khwaja N, Halka AT, Carter A, Turner NJ, et al. Expression of growth factors and growth factor receptor in non-healing and healing ischaemic ulceration. Eur J Vasc Endovasc Surg. 2006;31:516-22.
61. Sindram D, Porte RJ, Hoffman MR, Bentley RC, Clavien PA. Platelets induce sinusoidal endothelial cell apoptosis upon reperfusion of the cold ischemic rat liver. Gastroenterology. 2000;118:183-91.
62. Sindram D, Porte RJ, Hoffman MR, Bentley RC, Clavien PA. Synergism between platelets and leukocytes in inducing endothelial cell apoptosis in the cold ischemic rat liver: a Kupffer cell-mediated injury. Faseb J. 2001;15:1230-2.
63. Cywes R, Packham MA, Tietze L, Sanabria JR, Harvey PR, Phillips MJ, Strasberg SM. Role of platelets in hepatic allograft preservation injury in the rat. Hepatology. 1993;18:635-47.
64. Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, Gachet C, et al. Platelet-derived serotonin mediates liver regeneration. Science. 2006;312:104-7.
65. Brewer DB. Max Schultze (1865), G. Bizzozero (1882) and the discovery of the platelet. Br J Haematol. 2006;133:251-8.
66. Troxler M, Dickinson K, Homer-Vanniasinkam S. Platelet function and antiplatelet therapy. Br J Surg. 2007;94:674-82.
67. Mannaioni PF, Di Bello MG, Masini E. Platelets and inflammation: role of platelet-derived growth factor, adhesion molecules and histamine. Inflamm Res. 1997;46:4-18.
68. Witters P, Freson K, Verslype C, Peerlinck K, Hoylaerts M, Nevens F, Van Geet C, et al. Review article: Blood platelet number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther. 2008.
69. Poordad F. Review article: thrombocytopenia in chronic liver disease. Aliment Pharmacol Ther. 2007;26 Suppl 1:5-11.
70. Raines EW, Ross R. Purification of human platelet-derived growth factor. Methods Enzymol. 1985;109:749-73.
71. Nakamura T, Nawa K, Ichihara A, Kaise N, Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett. 1987;224:311-6.
72. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem. 1983;258:7155-60.
73. Assoian RK, Grotendorst GR, Miller DM, Sporn MB. Cellular transformation by coordinated action of three peptide growth factors from human platelets. Nature. 1984;309:804-6.
74. Rozman P, Boita Z. Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatovenerol Alp Panonica Adriat. 2007;16:156-65.
75. Strain AJ, McGowan JA, Bucher NL. Stimulation of DNA synthesis in primary cultures of adult rat hepatocytes by rat platelet-associated substance(s). In Vitro. 1982;18:108-16.
76. Kuwashima Y, Aoki K, Kohyama K, Ishikawa T. Hepatocyte regeneration after partial hepatectomy occurs even under severely thrombocytopenic conditions in the rat. Jpn J Cancer Res. 1990;81:607-12.
77. Tomikawa M, Hashizume M, Highashi H, Ohta M, Sugimachi K. The role of the spleen, platelets, and plasma hepatocyte growth factor activity on hepatic regeneration in rats. J Am Coll Surg. 1996;182:12-6.
78. Murata S, Ohkohchi N, Matsuo R, Ikeda O, Myronovych A, Hoshi R. Platelets promote liver regeneration in early period after hepatectomy in mice. World J Surg. 2007;31:808-16.
79. Matsuo R, Ohkohchi N, Murata S, Ikeda O, Nakano Y, Watanabe M, Hisakura K, et al. Platelets Strongly Induce Hepatocyte Proliferation with IGF-I and HGF In Vitro. J Surg Res. 2008;145:279-86.
80. Murata S, Matsuo R, Ikeda O, Myronovych A, Watanabe M, Hisakura K, Nakano Y, et al. Platelets Promote Liver Regeneration under Conditions of Kupffer Cell Depletion after Hepatectomy in Mice. World J Surg. 2008.
81. Lesurtel M, Soll C, Graf R, Clavien PA. Role of serotonin in the hepato-gastrointestinal tract: an old molecule for new perspectives. Cell Mol Life Sci. 2008;65:940-52.
82. Erspamer V, Asero B. Identification of enteramine, the specific hormone of the enterochromaffm cell system, as 5-hydro-xytryptamine. Nature. 1952;169:800-1.
83. Erspamer VVM. Ricerche sul secreto delle cellule enterocro-maffini. Boll Soc Med-Chir Pavia. 1937;51:357-63.
84. Gershon MD. Serotonergic neurotransmission in the gut. Scand J Gastroenterol Suppl. 1982;71:26-41.
85. Gershon MD. Review article: serotonin receptors and transporters - roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther. 2004;20 Suppl 7:3-14.
86. Gershon MD, Drakontides AB, Ross LL. Serotonin: Synthesis and Release from the Myenteric Plexus of the Mouse Intestine. Science. 1965;149:197-9.
87. Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007;132:397-414.
88. von der Ohe MR, Camilleri M, Kvols LK, Thomforde GM. Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med. 1993;329:1073-8.
89. McCuskey RS, Reilly FD, McCuskey PA, Dimlich RV. In vivo microscopy of the hepatic microvascular system. Bibl Anat. 1979:73-6.
90. Blankenship LL, Jr., Cilento EV, Reilly FD. Hepatic microvascular regulatory mechanisms. XI. Effects of serotonin on intralobular perfusion and volumetric flowrates at the inlet of periportal and outlet of centrivenous sinusoids. Microcirc Endothelium Lymphatics. 1991;7:57-75.
91. Nakamura N, Hamada N, Murata R, Kobayashi A, Ishizaki N, Taira A, Sakata R. Contribution of serotonin to liver injury following canine small-intestinal ischemia and reperfusion. J Surg Res. 2001;99:17-24.
92. Skolnik G, Bagge U, Dahlstrom A, Ahlman H.The importance of 5-HT for tumor cell lodgement in the liver. Int J Cancer. 1984;33:519-23.
93. Linder AE, Ni W, Diaz JL, Szasz T, Burnett R, Watts SW Serotonin (5-HT) in veins: not all in vain. J Pharmacol Exp Ther. 2007;323:415-21.
94. Walther DJ, Bader M.A unique central tryptophan hydroxylase isoform. Biochem Pharmacol. 2003;66:1673-80.
95. Ni W, Watts SW. 5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT). Clin Exp Pharmacol Physiol. 2006;33:575-83.
96. Marcos E, Adnot S, Pham MH, Nosjean A, Raffestin B, Hamon M, Eddahibi S. Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension. Am J Respir Crit Care Med. 2003;168:487-93.
97. Erspamer V, Testini A. Observations on the release and turnover rate of 5-hydroxytryptamine in the gastrointestinal tract. J Pharm Pharmacol. 1959;11:618-23.
98. Bertaccini G. Tissue 5-hydroxytryptamine and urinary 5- hydroxyindoleacetic acid after partial or total removal of the gastro-intestinal tract in the rat. J Physiol. 1960; 153:239-49.
99. Nocito A, Dahm F, Jochum W, Jang JH, Georgiev P, Bader M, Renner EL, et al. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis. Gastroenterology. 2007;133:608-18.
100. Gebauer A, Merger M, Kilbinger H. Modulation by 5-HT3 and 5-HT4 receptors of the release of 5-hydroxytryptamine from the guinea-pig small intestine. Naunyn Schmiedebergs Arch Pharmacol. 1993;347:137-40.
101. Bonhaus DW, Bach C, DeSouza A, Salazar FH, Matsuoka BD, Zuppan P, Chan HW, et al. The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors. Br J Pharmacol. 1995;115:622-8.
102. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 1999;38:1083-152.
103. Kim DY, Camilleri M. Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol. 2000;95:2698-2709.
104. Grider JR, Kuemmerle JF, Jin JG. 5-HT released by mucosal stimuli initiates peristalsis by activating 5-HT4/5-HTlp receptors on sensory CGRP neurons. Am J Physiol. 1996;270:778-82.
105. Furness JB, Kunze WA, Clerc N. Nutrient tasting and signaling mechanisms in the gut. II. The intestine as a sensory organ: neural, endocrine, and immune responses. Am J Physiol. 1999;277:922-8.
106. Yang M, Srikiatkhachorn A, Anthony M, Chong BH. Serotonin stimulates megakaryocytopoiesis via the 5-HT2 receptor. Blood Coagul Fibrinolysis. 1996;7:127-33.
107. Gooz M, Gooz P, Luttrell LM, Raymond JR. 5-HT2 A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells. J Biol Chem. 2006;281:21004-12.
108. Nebigil CG, Launay JM, Hickel P, Tournois C, Maroteaux L. 5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways. Proc Natl Acad Sci USA. 2000;97:2591-6.
109. Liu Y, Li M, Warburton RR, Hill NS, Fanburg BL. The 5-HT transporter transactivates the PDGFbeta receptor in pulmonary artery smooth muscle cells. Faseb J. 2007;21:2725-34.
110. Balasubramanian S, Paulose CS. Induction of DNA synthesis in primary cultures of rat hepatocytes by serotonin: possible involvement of serotonin S2 receptor. Hepatology. 1998;27:62-6.
111. Kulinskii AS, Saratikov AS, Vstavskaia Iu A, Udovitsina TI. [Effect of substances altering the metabolism of endogenous serotonin on mitotic activity in the regenerating liver of mice]. Farmakol Toksikol. 1983;46:92-5.
112. Basile AS, Jones EA, Skolnick P. The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands. Pharmacol Rev. 1991;43:27-71.
113. Jones EA. Fatigue associated with chronic liver disease: a riddle wrapped in a mystery inside an enigma. Hepatology. 1995;22:1606-8.
114. Lozeva-Thomas V. Serotonin brain circuits with a focus on hepatic encephalopathy. Metab Brain Dis. 2004;19:413-20.
115. Pyroja S, Joseph B, Paulose CS. Increased 5-HT2C receptor binding in the brain stem and cerebral cortex during liver regeneration and hepatic neoplasia in rats. J Neurol Sci. 2007;254:3-8.
116. Papadimas GK, Tzirogiannis KN, Panoutsopoulos GI, Demonakou MD, Skaltsas SD, Hereti RI, Papadopoulou-Daifoti Z, et al. Effect of serotonin receptor 2 blockage on liver regeneration after partial hepatectomy in the rat liver. Liver Int. 2006;26:352-61.
117. Nocito A, Georgiev P, Dahm F, Jochum W, Bader M, Graf R, Clavien PA. Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice. Hepatology. 2007;45:369-76.